BeStock  
Stocks › CSPCY

CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS CSPCY

US equityMarket cap rank #1129
$4.00 +$0.03 (+0.63%)
Market closed · Nov 22, 1:30 pm ET
Open$3.94
Prev close$3.97
Day range$3.93 – $3.96
Volume16.0K
Market cap$14.54B
P/E (TTM)10.8
Dividend yield4.21%

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

CSPCY at a glance

CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS stock (CSPCY) sits at $4.00, up 0.63% today. The business is worth $14.54B in the market, good for #1129 of 3753 on our coverage list.

Over a full year the shares have ranged across $3.26 to $5.46, which puts the current price roughly 33% of the way up that band. Holders are ahead 7.8% over twelve months, but down 13.0% across the last three months.

On the chart it has slipped under both the 50-day ($4.44) and 200-day ($4.32) moving averages; RSI is 37, and the last 30 sessions moved at roughly 37% annualized volatility.

Valuation works out to 10.8 times trailing earnings.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Volume16.0KAvg (90d) 1,471
Turnover$63,900.03
Turnover rate0.00%of shares outstanding
Day amplitude0.76%
Market cap$14.54B
Shares outstanding3.64B
EPS (TTM)$0.37
P/E (TTM)10.80
P/B2.02
Book value / share$1.98
Earnings yield9.26%
Dividend (TTM)$0.17 / shareYield 4.21%
30-day volatility37.1%annualized
Avg daily range (ATR)1.67%of price, 14 days
Max drawdown (1y)-38.5%-25.0% from 1y peak

Quote as of Nov 22, 2026 1:30 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

B
Valuation

Cheaper on P/E than most of BeStock’s coverage scores higher.

B
Income

Higher trailing yield than most of BeStock’s coverage scores higher.

D
Momentum

Trading closer to its 52-week high than most peers scores higher.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
+0.6%
1 week
-1.4%
1 month
-8.6%
3 months
-13.0%
6 months
+3.9%
Year to date
-5.2%
1 year
+7.8%
Day range
$3.93$3.96
52-week range
$3.26$5.46

Technical signals

Full technicals →
Trend readStrong downtrend

1 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-3.1%Bearish
Price vs 50-day average-10.0%Bearish
Price vs 200-day average-7.6%Bearish
50-day vs 200-day50d above 200dBullish
RSI (14)37.4Bearish
MACD (12,26,9)-0.11Bearish
Bollinger band position26%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How CSPCY ranks on BeStock

Market value#1128 of 3734
P/E (cheapest = 1)#691 of 2917
Dividend yield#530 of 2245
Closeness to 52-week high#1950 of 3724
Dollar volume today#3244 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

CSPCY is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on CSPCY.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on CSPCY

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

CSPCY stock: common questions

What is CSPCY's latest share price?

$4.00 is the latest print for CSPCY, a move of +0.63% against yesterday's close of $3.97. Today's low and high so far: $3.93 and $3.96.

How large is CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS by market value?

Equity value comes to $14.54B at the current price. By that measure it is number 1129 of the 3753 names in our coverage.

How is CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS valued against its profits?

Buyers pay 10.8 times the last twelve months of profit (EPS $0.37).

Is CSPCY near its 52-week high or low?

The year's floor is $3.26 and the ceiling $5.46. Shares are 26.8% away from that ceiling.

Does CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS pay a dividend?

It does. Payouts over the past twelve months work out to a 4.21% yield.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on CSPCY.

Sign in to join the discussion.

Scroll to Top